Significant differences between Crohn's disease and ulcerative colitis regarding the impact of body mass index and initial disease activity on responsiveness to azathioprine: results from a European multicenter study in 1,176 patients.
第一作者:
Martin H,Holtmann
第一单位:
1st Department of Medicine, Johannes Gutenberg University, Mainz, Germany. mholtman@mail.uni-mainz.de
作者:
医学主题词
消炎药(Anti-Inflammatory Agents);硫唑嘌呤(Azathioprine);人体质量指数(Body Mass Index);结肠炎, 溃疡性(Colitis, Ulcerative);Crohn病(Crohn Disease);用药计划表(Drug Administration Schedule);药物疗法, 联合(Drug Therapy, Combination);欧洲(Europe);随访研究(Follow-Up Studies);健康调查(Health Surveys);人类(Humans);免疫抑制剂(Immunosuppressive Agents);泼尼松龙(Prednisolone);二级预防(Secondary Prevention);治疗结果(Treatment Outcome)
DOI
10.1007/s10620-009-0846-9
PMID
19513841
发布时间
2021-10-20
- 浏览8
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



